The management of cyclosporine therapy in pediatric kidney-transplant recipients is largely based on single center's experience rather than on a univocal pharmacokinetic approach based on therapeutic drug monitoring. A prospective multicenter trial was designed to address the question whether C2 blood level monitoring of cyclosporine microemulsion therapy is feasible in the pediatric setting.
Pharmacokinetic of cyclosporine microemulsion in pediatric kidney recipients receiving a quadruple immunosuppressive regimen : the value of C2 blood levels / M. Ferraresso, L. Ghio, G. Zacchello, L. Murer, F. Ginevri, F. Perfumo, G.F. Zanon, I. Fontana, A. Amore, A. Edefonti, S. Vigano, M. Cardillo, M. Scalamogna. - In: TRANSPLANTATION. - ISSN 0041-1337. - 79:9(2005 May 15), pp. 1164-1168.
Pharmacokinetic of cyclosporine microemulsion in pediatric kidney recipients receiving a quadruple immunosuppressive regimen : the value of C2 blood levels
M. FerraressoPrimo
;
2005
Abstract
The management of cyclosporine therapy in pediatric kidney-transplant recipients is largely based on single center's experience rather than on a univocal pharmacokinetic approach based on therapeutic drug monitoring. A prospective multicenter trial was designed to address the question whether C2 blood level monitoring of cyclosporine microemulsion therapy is feasible in the pediatric setting.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
